SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-76844"
 

Search: onr:"swepub:oai:DiVA.org:uu-76844" > Do steroids increas...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis

Askling, J (author)
Karolinska Institutet
Klareskog, L (author)
Karolinska Institutet
Hjalgrim, H (author)
show more...
Baecklund, Eva (author)
Uppsala universitet,Reumatologi
Björkholm, M (author)
Karolinska Institutet
Ekbom, A (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
BMJ, 2005
2005
English.
In: Annals of the Rheumatic Diseases. - : BMJ. - 0003-4967 .- 1468-2060. ; 64:12, s. 1765-1768
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND:Recent studies indicate increased risks of malignant lymphomas among individuals treated with corticosteroids, but have not taken into account the underlying reasons for steroid use, so the increased risks might be attributable to the underlying disease or concomitant treatments other than steroids. Polymyalgia rheumatica (PMR) and temporal arteritis (giant cell arteritis, GCA) are common inflammatory conditions treated with steroids as single immunosuppressive therapy, but data on lymphoma risk in GCA/PMR are limited.OBJECTIVE:To assess the risk of lymphoma associated with steroid treatment of GCA/PMR.METHODS:The association between GCA/PMR and malignant lymphomas (overall, and separately for non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphatic leukaemia) was examined in a nationwide, population based, case-control study of 42,676 lymphoma cases and 78,487 matched population controls, using prospectively recorded data on lymphomas from the Swedish cancer register 1964-2000 and data on pre-lymphoma hospital admissions for GCA/PMR from the Swedish inpatient register 1964-2000. Odds ratios (OR) associated with a pre-lymphoma hospital admission for GCA/PMR were calculated using conditional logistic regression.RESULTS:153 lymphoma cases and 345 population controls had a history of GCA/PMR, resulting in an overall OR for malignant lymphomas of 0.81 (95% confidence interval, 0.67 to 0.98). The OR varied little with lymphoma type, sex, age, and calendar period. The OR for GCA was 0.67 (0.48 to 0.98) and for PMR, 0.83 (0.67 to 1.04).CONCLUSIONS:Treated GCA is not associated with increased lymphoma risks, which suggests that even at considerable cumulative doses, steroids may not appreciably increase lymphoma risk.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)

Keyword

Aged
Antirheumatic Agents/*adverse effects/therapeutic use
Epidemiologic Methods
Female
Glucocorticoids/*adverse effects/therapeutic use
Hodgkin Disease/chemically induced/epidemiology
Humans
Leukemia; Lymphocytic; Chronic/chemically induced/epidemiology
Lymphoma/*chemically induced/epidemiology
Lymphoma; Non-Hodgkin/chemically induced/epidemiology
Male
Middle Aged
Polymyalgia Rheumatica/*drug therapy
Research Support; Non-U.S. Gov't
Sweden/epidemiology
Temporal Arteritis/*drug therapy

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view